Connection

Michael Ostrowski to Molecular Targeted Therapy

Back to Details
This is a "connection" page, showing publications Michael Ostrowski has written about Molecular Targeted Therapy.
Michael Ostrowski
Connection Strength
0.030
Molecular Targeted Therapy
  1. Single agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancer. Oncotarget. 2015 Dec 29; 6(42):44509-22.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.